Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 33.23 -4.40% -1.53
ODT closed down 4.4 percent on Thursday, August 22, 2019, on 33 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ODT trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish -4.40%
Doji - Bearish? Reversal -4.40%
Wide Bands Range Expansion -4.40%
Up 3 Days in a Row Strength -4.40%
Oversold Stochastic Weakness -4.40%
Crossed Above 50 DMA Bullish -3.74%

Older signals for ODT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Cancer Pharmaceutical Iowa Corcept Therapeutics Urbandale
Is ODT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 6 Biopharma Investing With Avisol Capital: A Careful Balance Of Rules, Instincts (Podcast)
Jul 24 Odonate Therapeutics EPS beats by $0.05
Jul 24 Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019
Jul 9 Here's Why Odonate Therapeutics Stock Jumped 70.7% in June
Jul 2 The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug
Jun 28 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $20 million of Shares
Jun 28 The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO
Jun 27 The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO
Jun 26 Odonate Therapeutics: Making Taxanes Orally Available
Jun 26 Odonate Therapeutics prices follow-on offering at $26/share
See more ODT news...
Indicators
Indicator Value
52 Week High 43.75
52 Week Low 11.54
Average Volume 141,873
200-Day Moving Average 22.6891
50-Day Moving Average 34.5498
20-Day Moving Average 36.9695
10-Day Moving Average 34.103
Average True Range 2.2134
ADX 23.26
+DI 15.1053
-DI 25.2365
Chandelier Exit (Long, 3 ATRs ) 37.1098
Chandelier Exit (Short, 3 ATRs ) 38.1702
Upper Bollinger Band 43.2643
Lower Bollinger Band 30.6747
Percent B (%b) 0.2
BandWidth 34.054018
MACD Line -0.4496
MACD Signal Line 0.174
MACD Histogram -0.6236
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.81
Resistance 3 (R3) 37.00 36.00 36.21
Resistance 2 (R2) 36.00 35.09 35.90 36.01
Resistance 1 (R1) 34.62 34.53 34.12 34.42 35.81
Pivot Point 33.62 33.62 33.37 33.52 33.62
Support 1 (S1) 32.23 32.70 31.73 32.04 30.65
Support 2 (S2) 31.23 32.14 31.13 30.45
Support 3 (S3) 29.85 31.23 30.25
Support 4 (S4) 29.65